Molecular and clinical characterization of long-term effects in cancer survivors

Project start
Institution: Department of Hematology, Oncology and Cancer Immunology
Applicant: PD Dr Mareike Frick
EKFS funding line: Else Kröner Excellence Fellowships

Due to enormous medical progress, more and more patients can be healed from cancer. Unfortunately, cancer therapies often lead to severe late effects that can be associated with a pre-aged phenotype. However, we know little about the underlying cellular processes. In our project we aim to determine various measures of aging in the blood cells of young and middle-aged cancer patients and cancer survivors. Results will be linked to clinical and patient reported quality of life data. With this project, we aim to contribute to the improvement of the situation of cancer survivors.

Here you can find more information.